Literature DB >> 9220023

Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter.

T J Wood1, D Sliva, P E Lobie, F Goullieux, A L Mui, B Groner, G Norstedt, L A Haldosén.   

Abstract

The growth hormone regulated serine protease inhibitor (SPI) 2.1 and 2.2 gene promoters have been shown to contain a response element similar to the gamma-interferon activated sequence (GAS) family of signal transducer and activator of transcription (STAT) response elements. We have investigated the STAT and cytokine specificity of the SPI 2.1 STAT responsive element using a luciferase (LUC) reporter construct and a cDNA complementation strategy in the COS 7 cell line. Growth hormone was found to stimulate SPI-LUC reporter gene expression via activation of STAT 5, but not STATs 1 or 3, which indicates that the SPI 2.1 STAT responsive element is STAT 5 specific. In addition to the growth hormone receptor, the receptors for prolactin and erythropoietin enhanced gene transcription via the SPI 2.1 STAT responsive element, which indicates that this element is, on the other hand, not cytokine specific. Activation of STAT 5 was also observed after growth hormone treatment of cells transfected with cDNA expression plasmids for several different truncated growth hormone receptor mutants, although this activation was less efficient than with the wild type receptor. Point mutation of individual tyrosines in the growth hormone receptor intracellular domain to phenylalanines had no significant effect on signal transduction via STAT 5. These data, taken together with results from experiments using the phosphatase inhibitor sodium orthovanadate, suggest that STAT 5 may not have an absolute requirement for specific phosphorylated receptor tyrosine docking sites. That receptor tyrosine residues in a variety of amino acid contexts, or phosphorylated Janus kinase (JAK) 2 alone, can facilitate STAT 5 activation could explain the observed lack of cytokine specificity in STAT 5 activation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220023     DOI: 10.1016/s0303-7207(97)00075-0

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

1.  Overexpression of Xenopus laevis growth hormone stimulates growth of tadpoles and frogs.

Authors:  H Huang; D D Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Intrinsic sex differences in the early growth hormone responsiveness of sex-specific genes in mouse liver.

Authors:  Valerie Wauthier; Aarathi Sugathan; Rosana D Meyer; Alan A Dombkowski; David J Waxman
Journal:  Mol Endocrinol       Date:  2010-02-11

3.  A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.

Authors:  F Verdier; R Rabionet; F Gouilleux; C Beisenherz-Huss; P Varlet; O Muller; P Mayeux; C Lacombe; S Gisselbrecht; S Chretien
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

4.  Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.

Authors:  Emily M Fox; Teresa M Bernaciak; Jie Wen; Amanda M Weaver; Margaret A Shupnik; Corinne M Silva
Journal:  Mol Endocrinol       Date:  2008-06-11

5.  Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.

Authors:  Maurice Labuhn; Kelly Perkins; Sören Matzk; Leila Varghese; Catherine Garnett; Elli Papaemmanuil; Marlen Metzner; Alison Kennedy; Vyacheslav Amstislavskiy; Thomas Risch; Raj Bhayadia; David Samulowski; David Cruz Hernandez; Bilyana Stoilova; Valentina Iotchkova; Udo Oppermann; Carina Scheer; Kenichi Yoshida; Adrian Schwarzer; Jeffrey W Taub; John D Crispino; Mitchell J Weiss; Yasuhide Hayashi; Takashi Taga; Etsuro Ito; Seishi Ogawa; Dirk Reinhardt; Marie-Laure Yaspo; Peter J Campbell; Irene Roberts; Stefan N Constantinescu; Paresh Vyas; Dirk Heckl; Jan-Henning Klusmann
Journal:  Cancer Cell       Date:  2019-07-11       Impact factor: 31.743

6.  Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation.

Authors:  M Girardot; C Pecquet; I Chachoua; J Van Hees; S Guibert; A Ferrant; L Knoops; E J Baxter; P A Beer; S Giraudier; R Moriggl; W Vainchenker; A R Green; S N Constantinescu
Journal:  Oncogene       Date:  2014-03-31       Impact factor: 9.867

7.  In vivo identification of novel STAT5 target genes.

Authors:  Beth Basham; Manjiri Sathe; Jeffrey Grein; Terrill McClanahan; Annalisa D'Andrea; Emma Lees; Anne Rascle
Journal:  Nucleic Acids Res       Date:  2008-05-20       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.